Norwegian Marine Peptides

Proprietary bioactive marine peptides

  • Clinically proven & peer reviewed* to lower blood pressure
  • Effective for 89% of subjects in clinical trial
  • Documented MOA – Natural ACE inhibitor
  • Comparable effect to pharmaceuticals tested on same baseline population.
  • Therapeutic dose 1200mg
  • No significant side effects reported
Randomised Study

A Randomized, double-blind, placebo-controlled; multicentre, parallel study of the Effects of a Shrimp Protein Hydrolysate on Blood Pressure.

The results from this trial was published in the scientific journal:

International Journal of Hypertension

Clinical Evidence Overview
  • Reduction in office SBP statistically significant compared to placebo.
  • Reduction in daytime ambulatory SBP were statistically significant compared to placebo.
  • Statistically significant improvements for 24 hour SBP and for night time ambulatory SBP.
  • The ingredient outperformed Placebo on all DBP assessments.
  • Angiotensin II levels significantly reduced from baseline to week 8, documenting the ingredients mechanism of action.
  • No serious adverse effects reported.
  • No difference in safety parameters.
  • 89% percent of participants experienced a blood pressure reduction of medical significant after 8 weeks.